Media discourse on the social acceptability of fecal transplants

Qualitative Health Research

Volumn 25, Issue 10, 2015, Pages 1359-1371

  Chuong, Kim H ^a   O'Doherty, Kieran C ^a   Secko, David M ^b  

^a UNIVERSITY OF GUELPH   (Canada)

^b Gina Cody School of Engineering and Computer Science   (Canada)

Author keywords

discourse analysis; fecal transplants; human microbiome; ick factor; media representations

Indexed keywords

CANADA; FECAL MICROBIOTA TRANSPLANTATION; HUMAN; INTESTINE FLORA; MASS MEDIUM; PSYCHOLOGY; STATISTICS AND NUMERICAL DATA;

CANADA; FECAL MICROBIOTA TRANSPLANTATION; GASTROINTESTINAL MICROBIOME; HUMANS; MASS MEDIA;

EID: 84941253579     PISSN: 10497323     EISSN: 15527557     Source Type: Journal    
DOI: 10.1177/1049732314568199     Document Type: Article

References (64)

1. Allen-Vercoe E., Petrof E. O., (2013). Artificial stool transplantation: Progress towards a safer, more effective and acceptable alternative. Expert Review of Gastroenterology & Hepatology, 7, 291-293. doi: 10.1586/EGH.13.16
2. Allen-Vercoe E., Reid G., Viner N., Gloor G. B., Hota S., Kim P.,. Petrof E. O., (2012). A Canadian Working Group report on fecal microbial therapy: Microbial ecosystem therapeutics. Canadian Journal of Gastroenterology, 26, 457-462. Retrieved from http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3395448/
3. Applbaum K., (2009). Is marketing the enemy of pharmaceutical innovation? Hastings Center Report, 39 (4), 13-17. doi: 10.1353/hcr.0.0157
4. Balas E. A., Boren S. A., (2000). Managing clinical knowledge for health care improvement. In Bemmel J. H., McCray A. T., (Eds.), Yearbook of medical informatics 2000: Patient-centered systems (pp. 65-70). Stuttgart, Germany: Schattauer.
5. Blandino M. V., Govantes M. A. G., Chaves V. C., Palomo P. P., Blanco G. B., Roncero F. M. G.,. López R. M., (2011). Information channels and the dynamics of uptake of living kidney donors: A retrospective study in a reference area. Transplantation Proceedings, 43, 2157-2159. doi: 10.1016/j.transproceed.2011.05.004
6. Brandt L. J., Borody T. J., Campbell J., (2011). Endoscopic fecal microbiota transplantation: "First-line"? treatment for severe Clostridium difficile infection? Journal of Clinical Gastroenterology, 45, 655-657. doi: 10.1097/MCG.0b013e3182257d4f
7. Braun K. L., Nichols R., (1997). Death and dying in four Asian American cultures: A descriptive study. Death Studies, 21, 327-359. doi: 10.1080/074811897201877
8. Busfield J., (2006). Pills, power, people: Sociological understandings of the pharmaceutical industry. Sociology, 40, 297-314. doi: 10.1177/0038038506062034
9. Busfield J., (2010). "A pill for every ill"?: Explaining the expansion in medicine use. Social Science & Medicine, 70, 934-941. doi: 10.1016/j.socscimed.2009.10.068
10. Conrad P., (1999). Uses of expertise: Sources, quotes, and voice in the reporting of genetics in the news. Public Understanding of Science, 8, 285-302. doi: 10.1088/0963-6625/8/4/302
11. Conrad P., (2001). Genetic optimism: Framing genes and mental illness in the news. Culture, Medicine, and Psychiatry, 25, 225-247. doi: 10.1023/A:1010690427114
12. Conrad P., Barker K. K., (2010). The social construction of illness: Key insights and policy implications. Journal of Health and Social Behavior, 51 (1 Suppl.), 567-579. doi: 10.1177/0022146510383495
13. Crabb S., Lecouteur A., (2006). "Fiona farewells her breasts"?: A popular magazine account of breast cancer prevention. Critical Public Health, 16, 5-18. doi: 10.1080/09581590600601957
14. Dethlefsen L., McFall-Ngai M., Relman D. A., (2007). An ecological and evolutionary perspective on human-microbe mutualism and disease. Nature, 449, 811-818. doi: 10.1038/nature06245
15. Edley N., (2001). Unravelling social constructionism. Theory & Psychology, 11, 433-441. doi: 10.1177/0959354301113008
16. Edwards D., Potter J., (1992). Discursive psychology. London: Sage.
17. Eiseman B., Silen W., Bascom G. S., Kauvar A. J., (1958). Fecal enema as an adjunct in the treatment of pseudomembranous enterocolitis. Surgery, 44, 854-859.
18. Ettinger G., Burton J. P., Reid G., (2013). If microbial ecosystem therapy can change your life, what's the problem? Bioessays, 35, 508-512. doi: 10.1002/bies.201300015
19. Fragomeni C., Powell N., Walters J., (2008,). Out of control. The Hamilton Spectator. Retrieved from http://www.michenerawards.ca/english/stories2008/C.Diff.htm
20. Gergen K., (1985). The social constructionist movement in modern psychology. American Psychologist, 40, 266-275. doi: 10.1037/0003-066X.40.3.266
21. Gerrard N., (1994). The notion of gift-giving and organ donation. Bioethics, 8, 127-150. doi: 10.1111/j.1467-8519.1994.tb00250.x
22. Gordon J. I., (2012). Honor thy gut symbionts redux. Science, 336, 1251-1253. doi: 10.1126/science.1224686
23. Gough E., Shaikh H., Manges A. R., (2011). Systematic review of intestinal microbiota transplantation (fecal bacteriotherapy) for recurrent Clostridium difficile infection. Clinical Infectious Diseases, 53, 994-1002. doi: 10.1093/cid/cir632
24. Green L. W., Ottoson J. M., García C., Hiatt R. A., (2009). Diffusion theory and knowledge dissemination, utilization, and integration in public health. Annual Review of Public Health, 30, 151-174. doi: 10.1146/annurev.publhealth.031308.100049
25. Guo B., Harstall C., Nguyen T., Ohinmaa A., (2011). Alberta STE report: Fecal transplantation for the treatment of Clostridium difficile-associated disease or ulcerative colitis. Edmonton: Institute of Health Economics. Retrieved from http://www.ihe.ca/publications/library/2011/
26. Hawkins A. K., O'Doherty K. C., (2011). "Who owns your poop?"?: Insights regarding the intersection of human microbiome research and the ELSI aspects of biobanking and related studies. BMC Medical Genomics, 4, 72-80. doi: 10.1186/1755-8794-4-72
27. Henderson L., Kitzinger J., (1999). The human drama of genetics: "Hard"? and "soft"? media representations of inherited breast cancer. Sociology of Health & Illness, 21, 560-578. doi: 10.1111/1467-9566.00173
28. Kachur T., (2013, 10). Can your body's bacteria cause mental health problems? CBC Radio West. Retrieved from http://www.cbc.ca/player/Radio/Local+Shows/British+Columbia/Radio+West/ID/2411561612/
29. Kahn S. A., Gorawara-Bhat R., Rubin D. T., (2012). Fecal bacteriotherapy for ulcerative colitis: Patients are ready, are we? Inflammatory Bowel Diseases, 18, 676-684. doi: 10.1002/ibd.21775
30. Kelly C. P., LaMont J. T., (2008). Clostridium difficile-More difficult than ever. The New England Journal of Medicine, 359, 1932-1940. doi: 10.1056/NEJMra0707500
31. Khoruts A., Sadowsky M. J., (2011). Therapeutic transplantation of the distal gut microbiota. Mucosal Immunology, 4, 4-7. doi: 10.1038/mi.2010.79
32. Klein H. G., (2001). Will blood transfusion ever be safe enough? Transfusion Medicine, 11, 122-124. doi: 10.1046/j.1365-3148.2001.00295-5.x
33. Kleinknecht R. A., Kleinknecht E. E., Thorndike R. M., (1997). The role of disgust and fear in blood and injection-related fainting symptoms: A structural equation model. Behaviour Research and Therapy, 35, 1075-1087. doi: 10.1016/S0005-7967(97)10010-9
34. Lambert P. J., Dyck M., Thompson L. H., Hammond G. W., (2009). Population-based surveillance of Clostridium difficile infection in Manitoba, Canada, by using interim surveillance definitions. Infection Control & Hospital Epidemiology, 30, 945-951. doi: 10.1086/605719
35. Landy J., Al-Hassi H. O., McLaughlin S. D., Walker A. W., Ciclitira P. J., Nicholls R. J.,. Hart A. L., (2011). Review article: Faecal transplantation therapy for gastrointestinal disease. Alimentary Pharmacology & Therapeutics, 34, 409-415. doi: 10.1111/j.1365-2036.2011.04737.x
36. Lessa F. C., Gould C. V., McDonald L. C., (2012). Current status of Clostridium difficile infection epidemiology. Clinical Infectious Diseases, 55 (Suppl. 2), S65-S70. doi: 10.1093/cid/cis319
37. Lyons A. C., (2000). Examining media representations: Benefits for health psychology. Journal of Health Psychology, 5, 349-358. doi: 10.1177/135910530000500307
38. McCollum D. L., Rodriguez J. M., (2012). Detection, treatment, and prevention of Clostridium difficile infection. Clinical Gastroenterology and Hepatology, 10, 581-592. doi: 10.1016/j.cgh.2012.03.008
39. Moayyedi P., Marshall J. K., Yuan Y., Hunt R., (2014). Canadian Association of Gastroenterology position statement: Fecal microbiota transplant therapy. Journal of Canadian Gastroenterology & Hepatology, 28, 66-68.
40. Morgan S. E., Stephenson M. T., Harrison T. R., Afifi W. A., Long S. D., (2008). Facts versus "feelings"?: How rational is the decision to become an organ donor? Journal of Health Psychology, 13, 644-658. doi: 10.1177/1359105308090936
41. Morris Z. L., Wooding S., Grant J., (2011). The answer is 17 years, what is the question: Understanding time lags in translational research. Journal of the Royal Society of Medicine, 104, 510-520. doi: 10.1258/jrsm.2011.110180
42. Nerlich B., Hellsten I., (2007). Beyond the human genome: Microbes, metaphors and what it means to be human in an interconnected post-genomic world. New Genetics & Society, 28, 19-36. doi: 10.1080/14636770802670233
43. Nisbet M. C., Lewenstein B. V., (2002). Biotechnology and the American media: The policy process and the elite press, 1970 to 1999. Science Communication, 23, 359-391. doi: 10.1177/107554700202300401
44. Nisbet M. C., Scheufele D. A., (2009). What's next for science communication? Promising directions and lingering distractions. American Journal of Botany, 96 (10), 1767-1778. doi: 10.3732/ajb.0900041.
45. O'Carroll R. E., Foster C., McGeechan G., Sandford K., Ferguson E., (2011). The "ick"? factor, anticipated regret, and willingness to become an organ donor. Health Psychology, 30, 236-245. doi: 10.1037/a0022379
46. Page A. C., (2003). The role of disgust in faintness elicited by blood and injection stimuli. Journal of Anxiety Disorders, 17, 45-58. doi: 10.1016/S0887-6185(02)00169-X
47. Pépin J., Valiquette L., Cossette B., (2005). Mortality attributable to nosocomial Clostridium difficile -associated disease during an epidemic caused by a hypervirulent strain in Quebec. Canadian Medical Association Journal, 173, 1037-1042. doi: 10.1503/cmaj.050978
48. Petersen A., (2001). Biofantasies: Genetics and medicine in the print news media. Social Science & Medicine, 52, 1255-1268. doi: 10.1016/S0277-9536(00)00229-X
49. Petrof E. O., Gloor G. B., Vanner S. J., Weese S. J., Carter D., Daigneault M. C.,. Allen-Vercoe E., (2013). Stool substitute transplant therapy for the eradication of Clostridium difficile infection: "RePOOPulating"? the gut. Microbiome, 1, Article 3. doi: 10.1186/2049-2618-1-3
50. Potter J., (1996). Representing reality: Discourse, rhetoric and social construction. London: Sage.
51. Potter J., Wetherell M., (1987). Discourse and social psychology: Beyond attitudes and behaviour. London: Sage.
52. Rabinow P., (1999). French DNA: Trouble in purgatory. Chicago: University of Chicago Press.
53. Rhodes R., Gligorov N., Schwab A. P., (Eds.). (2013). The human microbiome: Ethical, legal and social concerns. New York: Oxford University Press.
54. Slashinski M. J., McCurdy S. A., Achenbaum L. S., Whitney S. N., McGuire A. L., (2012). "Snake-oil,"? "quack medicine,"? and "industrially cultured organisms"?: Biovalue and the commercialization of human microbiome research. BMC Medical Ethics, 13, 28-35. doi: 10.1186/1472-6939-13-28
55. Spielmans G. I., Parry P. I., (2010). From evidence-based medicine to marketing-based medicine: Evidence from internal industry documents. Journal of Bioethical Inquiry, 7, 13-29. doi: 10.1007/s11673-010-9208-8
56. Sque M., Payne S., Clark J. M., (2006). Gift of life or sacrifice?: Key discourses to understanding organ donor families' decision-making. Mortality, 11, 117-132. doi: 10.1080/13576270600615260
57. Starr D., (2001). Medicine, money, and myth: An epic history of blood. Transfusion Medicine, 11, 119-121. doi: 10.1046/j.1365-3148.2001.00295-5.x
58. Suwantarat N., Bobak D. A., (2011). Current status of nonantibiotic and adjunct therapies for Clostridium difficile infection. Current Infectious Disease Reports, 13, 21-27. doi: 10.1007/s11908-010-0155-7
59. Titmuss R. M., (1970). The gift relationship: From human blood to social policy. London: George Allen & Unwin.
60. Tolin D. F., Lohr J. M., Sawchuk C. N., Lee T. C., (1997). Disgust and disgust sensitivity in blood-injection-injury and spider phobia. Behaviour Research and Therapy, 35, 949-953. doi: 10.1016/S0005-7967(97)00048-X
61. van Nood E., Speelman P., Kujiper E. J., Keller J. J., (2009). Struggling with recurrent Clostridium difficile infections: Is donor faeces the solution? EuroSurveillance, 14, 465-470. Retrieved from http://www.eurosurveillance.org/ViewArticle.aspx?ArticleId=19316
62. van Nood E., Vrieze A., Nieuwdorp M., Fuentes S., Zoetendal E. G., de Vos W. M.,. Keller J. J., (2013). Duodenal infusion of donor feces for recurrent. Clostridium difficile. The New England Journal of Medicine, 368, 407-415. doi: 10.1056/NEJMoa1205037
63. Weissman J. S., Coyle W., (2012). Stool transplants: Ready for prime time? Current Gastroenterology Reports, 14, 313-316. doi: 10.1007/s11894-012-0263-7
64. Zipursky J. S., Sidorsky T. I., Freedman C. A., Sidorsky M. N., Kirkland K. B., (2012). Patient attitudes towards the use of fecal microbiota transplantation in the treatment of recurrent Clostridium difficile infection. Clinical Infectious Diseases, 55, 1652-1658. doi: 10.1093/cid/cis809